Quick Answer
AtriCure, Inc. reported Operating Income Loss of -$9.45 million for the year ending 2025.
- AtriCure, Inc. showed an increase of +76.4% in Operating Income Loss from 2024 to 2025.
- This data is from AtriCure, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: -$7.93 million | Q2 2014: -$2.85 million | Q3 2014: -$803.0 thousand | Q4 2014: -$4.78 million | Q1 2015: -$5.14 million | Q2 2015: -$4.82 million | Q3 2015: -$6.13 million | Q4 2015: -$10.63 million | Q1 2016: -$9.42 million | Q2 2016: -$7.74 million | Q3 2016: -$6.29 million | Q4 2016: -$7.70 million | Q1 2017: -$9.64 million | Q2 2017: -$6.36 million | Q3 2017: -$6.85 million | Q4 2017: -$2.14 million | Q1 2018: -$9.43 million | Q2 2018: $958.0 thousand | Q3 2018: -$6.05 million | Q4 2018: -$2.61 million | Q1 2019: -$5.32 million | Q2 2019: -$3.84 million | Q3 2019: -$8.64 million | Q4 2019: -$15.33 million | Q1 2020: -$15.45 million | Q2 2020: -$7.29 million | Q3 2020: -$3.99 million | Q4 2020: -$17.50 million | Q1 2021: -$15.89 million | Q2 2021: -$15.08 million | Q3 2021: $98.67 million | Q1 2022: -$14.15 million | Q2 2022: -$13.66 million | Q3 2022: -$10.72 million | Q1 2023: -$5.78 million | Q2 2023: -$4.14 million | Q3 2023: -$8.09 million | Q1 2024: -$10.92 million | Q2 2024: -$7.17 million | Q3 2024: -$7.41 million | Q1 2025: -$5.95 million | Q2 2025: -$6.19 million | Q3 2025: $208.0 thousand.
- Over the full 17 years of available data (2009 to 2025), AtriCure, Inc.'s Operating Income Loss has grown by 39.1%.
- Historical annual values: Fiscal year 2025: -$9.45 million | Fiscal year 2024: -$40.01 million | Fiscal year 2023: -$26.68 million | Fiscal year 2022: -$42.67 million | Fiscal year 2021: $55.21 million | Fiscal year 2020: -$44.23 million | Fiscal year 2019: -$33.12 million | Fiscal year 2018: -$17.13 million | Fiscal year 2017: -$24.98 million | Fiscal year 2016: -$31.14 million | Fiscal year 2015: -$26.72 million | Fiscal year 2014: -$16.36 million | Fiscal year 2013: -$10.89 million | Fiscal year 2012: -$7.20 million | Fiscal year 2011: -$4.73 million | Fiscal year 2010: -$3.19 million | Fiscal year 2009: -$15.51 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: